Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma
Weiwei Wang,1,* Lei Wang,2,* Qingqing Fan,3,* Jingyan Xu,1 Yifan Li,4 Jiale Xu,4 Bei Zhao,2 Dan Ge,2 Longying Xiong,2 Yanping Wu,2 Yun Zhu,4,5 Min Chen4 1Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medici...
Saved in:
| Main Authors: | Wang W, Wang L, Fan Q, Xu J, Li Y, Zhao B, Ge D, Xiong L, Wu Y, Zhu Y, Chen M |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/macrophage-membrane-coated-liposomes-delivering-vonoprazan-disrupt-mit-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01) -
Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori
by: Jing Yu, et al.
Published: (2024-11-01) -
Efficacy and cost-effectiveness analysis of 10-day versus 14-day eradication of Helicobacter pylori infection with vonoprazan amoxicillin: a prospective, multicenter, randomized controlled trial
by: Yunfan Dong, et al.
Published: (2025-03-01) -
Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial
by: Yumna M. Shekeban, et al.
Published: (2025-05-01) -
Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with Helicobacter pylori infection: a meta-analysis
by: Xiao Li, et al.
Published: (2025-03-01)